Zeiss acquires IP from Mitsui Chemicals

zeiss-logo-rgb

Zeiss Vision Care has acquired a “comprehensive intellectual property (IP) portfolio, including a suite of patents,” from Mitsui Chemicals (MCI), a Japanese company with wide-ranging business lines, among them “vision care materials,” and an R&D department split between synthesis, polymer science and tech for manufacturing processes. Zeiss has not disclosed ...

Already an Eyewear Intelligence subscriber? Sign in here.

barrier_image_OIC

Subscribe today

Buying a membership today will give you:

  • Unlimited access to ewintelligence.com - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation
  • Organisation-wide access across offices, people and devices

To continue reading this article register now.